Identification of germline MLH1 alterations in familial prostate cancer

European Journal of Cancer

Volumn 42, Issue 16, 2006, Pages 2802-2806

  Fredriksson, H ^a   Ikonen, T ^a   Autio, V ^b   Matikainen, M P ^b   Helin, H J ^b,c   Tammela, T L J ^b   Koivisto, P A ^a,d   Schleutker, J ^a  

^a UNIVERSITY OF TAMPERE   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^d Tampere University Hospital ^*  (Finland)

Author keywords

Germ line mutation; I219V; MLH1; P434L; Prostate cancer; V647M

Indexed keywords

PROTEIN; PROTEIN MHL1; PROTEIN MSH2; PROTEIN MSH6; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER SCREENING; COLON CANCER; CONTROLLED STUDY; FAMILIAL CANCER; FINLAND; GENE MUTATION; GENE SEQUENCE; GENETIC VARIABILITY; HETEROZYGOTE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY;

ADULT; AGED; AGED, 80 AND OVER; CARRIER PROTEINS; GERM-LINE MUTATION; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MUTATION, MISSENSE; NUCLEAR PROTEINS; PEDIGREE; PROSTATIC NEOPLASMS; REGISTRIES;

EID: 33751017687     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2006.04.024     Document Type: Article

References (32)

1. Crawford E.D. Epidemiology of prostate cancer. Urology 62 (2003) 3-12
2. Lichtenstein P., Holm N.V., Verkasalo P.K., et al. Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 343 (2000) 78-85
3. Tavtigian S.V., Simard J., Teng D.H., et al. A candidate prostate cancer susceptibility gene at chromosome 17p. Nat Genet 27 (2001) 172-180
4. Carpten J., Nupponen N., Isaacs S., et al. Germline mutations in the ribonuclease L gene in families showing linkage with HPC1. Nat Genet 30 (2002) 181-184
5. Xu J., Zheng S.L., Komiya A., et al. Germline mutations and sequence variants of the macrophage scavenger receptor 1 gene are associated with prostate cancer risk. Nat Genet 32 (2002) 321-325
6. Schleutker J., Matikainen M., Smith J., et al. A genetic epidemiological study of hereditary prostate cancer (HPC) in Finland: frequent HPCX linkage in families with late-onset disease. Clin Cancer Res 6 (2000) 4810-4815
7. Chang B.L., Gillanders E.M., Isaacs S.D., et al. Evidence for a general cancer susceptibility locus at 3p24 in families with hereditary prostate cancer. Cancer Lett 219 (2005) 177-182
8. Chang B.L., Isaacs S.D., Wiley K.E., et al. Genome-wide screen for prostate cancer susceptibility genes in men with clinically significant disease. Prostate 64 (2005) 356-361
9. Peltomaki P., and Vasen H.F. Mutations predisposing to hereditary nonpolyposis colorectal cancer: database and results of a collaborative study. The International Collaborative Group on Hereditary Nonpolyposis Colorectal Cancer. Gastroenterology 113 (1997) 1146-1158
10. Egawa S., Uchida T., Suyama K., et al. Genomic instability of microsatellite repeats in prostate cancer: relationship to clinicopathological variables. Cancer Res 55 (1994) 2415-2421
11. Gao X., Wu N., Grignon D., et al. High frequency of mutator phenotype in human prostatic adenocarcinoma. Oncogene 9 (1994) 2999-3003
12. Watanabe M., Imai H., Shiraishi T., Shimazaki J., Kotake T., and Yatani R. Microsatellite instability in human prostate cancer. Br J Cancer 72 (1995) 562-564
13. Chen Y., Wang J., Fraig M.M., et al. Alterations in PMS2, MSH2 and MLH1 expression in human prostate cancer. Int J Oncol 22 (2003) 1033-1043
14. Yeh C.C., Lee C., and Dahiya R. DNA mismatch repair enzyme activity and gene expression in prostate cancer. Biochem Biophys Res Commun 285 (2001) 409-413
15. Dumur C.I., Dechsukhum C., Ware J.L., et al. Genome-wide detection of LOH in prostate cancer using human SNP microarray technology. Genomics 81 (2003) 260-269
16. Dahiya R., McCarville J., Hu W., et al. Chromosome 3p24-26 and 3p22-12 loss in human prostatic adenocarcinoma. Int J Cancer 71 (1997) 20-25
17. Burmester J.K., Suarez B.K., Lin J.H., et al. Analysis of candidate genes for prostate cancer. Hum Hered 57 (2004) 172-178
18. Rokman A., Baffoe-Bonnie A.B., Gillanders E., et al. Hereditary prostate cancer in Finland: fine-mapping validates 3p26 as a major predisposition locus. Hum Genet 116 (2005) 43-50
19. Muller W., Burgart L.J., Krause-Paulus R., et al. The reliability of immunohistochemistry as a prescreening method for the diagnosis of hereditary nonpolyposis colorectal cancer (HNPCC)-results of an international collaborative study. Fam Cancer 1 (2001) 87-92
20. Seppala E.H., Ikonen T., Autio V., et al. Germ-line alterations in MSR1 gene and prostate cancer risk. Clin Cancer Res 9 (2003) 5252-5256
21. Syvänen A.C. Solid-phase minisequencing as a tool to detect DNA polymorphism. Methods Mol Biol 98 (1998) 291-298
22. Liu B., Nicolaides N.C., Markowitz S., et al. Mismatch repair gene defects in sporadic colorectal cancers with microsatellite instability. Nat Genet 9 (1995) 48-55
23. Tannergard P., Lipford J.R., Kolodner R., Frodin J.E., Nordenskjold M., and Lindblom A. Mutation screening in the hMLH1 gene in Swedish hereditary nonpolyposis colon cancer families. Cancer Res 55 (1995) 6092-6096
24. Percesepe A., Borghi F., Menigatti M., et al. Molecular screening for hereditary nonpolyposis colorectal cancer: a prospective, population-based study. J Clin Oncol 19 (2001) 3944-3950
25. Hudler P., Vouk K., Liovic M., Repse S., Juvan R., and Komel R. Mutations in the hMLH1 gene in Slovenian patients with gastric carcinoma. Clin Genet 65 (2004) 405-411
26. Chen Y., Wang J., Fraig M.M., et al. Defects of DNA mismatch repair in human prostate cancer. Cancer Res 61 (2001) 4112-4121
27. Schleutker J., Baffoe-Bonnie A.B., Gillanders E., et al. Genome-wide scan for linkage in finnish hereditary prostate cancer (HPC) families identifies novel susceptibility loci at 11q14 and 3p25-26. Prostate 57 (2003) 280-289
28. Schatzkin A., Baranovsky A., and Kessler L.G. Diet and cancer. Evidence from associations of multiple primary cancers in the SEER program. Cancer 62 (1988) 1451-1457
29. Enblad P., Adami H.O., Glimelius B., Krusemo U., and Pahlman L. The risk of subsequent primary malignant diseases after cancers of the colon and rectum. A nationwide cohort study. Cancer 65 (1990) 2091-2100
30. Bittorf B., Kessler H., Merkel S., et al. Multiple primary malignancies: An epidemiological and pedigree analysis of 57 patients with at least three tumours. Eur J Surg Oncol 27 (2001) 302-313
31. Bagnoli S., Putignano A.L., Melean G., et al. Susceptibility to refractory ulcerative colitis is associated with polymorphism in the hMLH1 mismatch repair gene. Inflamm Bowel Dis 10 (2004) 705-708
32. Trojan J., Zeuzem S., Randolph A., et al. Functional analysis of hMLH1 variants and HNPCC-related mutations using a human expression system. Gastroenterology 122 (2002) 211-219